MedTrace Logo

Effects of Furosemide Plus Small HSS in Subjects With Heart Failure With Reduced Ejection Fraction (HFrEF)

NCT04628325 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 136

Last updated 2020-11-13

No results posted yet for this study

Summary

The investigators sought to evaluate the effectiveness of treatment with furosemide + HSS in terms of reduction of serum levels of some chosen markers of heart failure and the response in terms of these markers at a compensated state after an acute saline load.

Conditions

  • Heart Failure，Congestive

Interventions

DRUG

Furosemide

Intravenous Furosemide Plus Small Hypertonic Saline Solutions (HSS)

Sponsors & Collaborators

  • University of Palermo

    lead OTHER

Principal Investigators

  • Antonino Tuttolomondo, PhD · Internal Medicine and Stroke Care Ward, University of Palermo, Italy

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-03-01
Primary Completion
2019-06-30
Completion
2020-05-01

Countries

  • Italy

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04628325 on ClinicalTrials.gov